O
Oivi
Preventing blindness among diabetes patients by deploying an AI-camera for automated diagnosis of retinal diseases
About Oivi
Developer of an online platform designed for tracking eye diseases through teleconsultation. The company's platform uses a camera for retinal screening with automated image capture and diagnostics to detect diabetes-related eye diseases, enabling patients to prevent permanent eye blindness. Keywords: Healthcare Devices, Services, Supplies, Blindness Treatment, Camera Platform, Diabetes-Related Blindness, Eye Disease Treatment, Eye Hospital, Eye Treatment.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- Oslo, Norway
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
Research Council of Norway
Innovation Norway
European Innovation Council
Arali Ventures
Farvatn Venture
Stratel
Planet 9 Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Oivi on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Oivi on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.